Capital Allergy and Respiratory Disease Center is a clinical research site located in Roseville, California, United States 95661.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Capital Allergy and Respiratory Disease Center has participated in 1 clinical trials.
Therapeutic areas: Pulmonary Disease, Chronic Obstructive.
Sponsors: Boehringer Ingelheim.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Capital Allergy and Respiratory Disease Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Capital Allergy and Respiratory Disease Center has 1 clinical trials on record. Their work covers Pulmonary Disease, Chronic Obstructive.
Capital Allergy and Respiratory Disease Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.